Learning to detect lymphocytes in immunohistochemistry with deep learning

The immune system is of critical importance in the development of cancer. The evasion of destruction by the immune system is one of the emerging hallmarks of cancer. We have built a dataset of 171,166 manually annotated CD3+ and CD8+ cells, which we used to train deep learning algorithms for automatic detection of lymphocytes in histopathology images to better quantify immune response. Moreover, we investigate the effectiveness of four deep learning based methods when different subcompartments of the whole-slide image are considered: normal tissue areas, areas with immune cell clusters, and areas containing artifacts. We have compared the proposed methods in breast, colon and prostate cancer tissue slides collected from nine different medical centers. Finally, we report the results of an observer study on lymphocyte quantification, which involved four pathologists from different medical centers, and compare their performance with the automatic detection. The results give insights on the applicability of the proposed methods for clinical use. U-Net obtained the highest performance with an F1-score of 0.78 and the highest agreement with manual evaluation (κ=0.72), whereas the average pathologists agreement with reference standard was κ=0.64. The test set and the automatic evaluation procedure are publicly available at lyon19.grand-challenge.org.

[1]  Jianzhong Wu,et al.  Stacked Sparse Autoencoder (SSAE) for Nuclei Detection on Breast Cancer Histopathology Images , 2016, IEEE Transactions on Medical Imaging.

[2]  Chaya S Moskowitz,et al.  Using Free-Response Receiver Operating Characteristic Curves to Assess the Accuracy of Machine Diagnosis of Cancer. , 2017, JAMA.

[3]  Rajarsi R. Gupta,et al.  Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. , 2018, Cell reports.

[4]  Andrew Janowczyk,et al.  Deep learning for digital pathology image analysis: A comprehensive tutorial with selected use cases , 2016, Journal of pathology informatics.

[5]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[6]  Geert J. S. Litjens,et al.  Convolutional Neural Networks for Lymphocyte detection in Immunohistochemically Stained Whole-Slide Images , 2018 .

[7]  Nasir M. Rajpoot,et al.  Locality Sensitive Deep Learning for Detection and Classification of Nuclei in Routine Colon Cancer Histology Images , 2016, IEEE Trans. Medical Imaging.

[8]  Lin Yang,et al.  Robust Nucleus/Cell Detection and Segmentation in Digital Pathology and Microscopy Images: A Comprehensive Review , 2016, IEEE Reviews in Biomedical Engineering.

[9]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[10]  Xiang Zhang,et al.  OverFeat: Integrated Recognition, Localization and Detection using Convolutional Networks , 2013, ICLR.

[11]  Colin Raffel,et al.  Lasagne: First release. , 2015 .

[12]  Ross B. Girshick,et al.  Fast R-CNN , 2015, 1504.08083.

[13]  J. Fleiss Statistical methods for rates and proportions , 1974 .

[14]  Andrew H. Beck,et al.  Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer , 2017, JAMA.

[15]  Hai Su,et al.  Beyond Classification: Structured Regression for Robust Cell Detection Using Convolutional Neural Network , 2015, MICCAI.

[16]  Meyke Hermsen,et al.  1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset , 2018, GigaScience.

[17]  Adv Anat Pathol Scoring of tumor-infiltrating lymphocytes : from visual estimation to machine learning , 2019 .

[18]  Subhashini Venugopalan,et al.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.

[19]  F. Ciompi,et al.  You Only Look on Lymphocytes Once , 2018 .

[20]  Kaiming He,et al.  Faster R-CNN: Towards Real-Time Object Detection with Region Proposal Networks , 2015, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[21]  Silun Xie,et al.  Allogenic natural killer cell immunotherapy of sizeable ovarian cancer: A case report , 2017, Molecular and clinical oncology.

[22]  Luis Cano,et al.  Automatic Lymphocyte Detection on Gastric Cancer IHC Images Using Deep Learning , 2017, 2017 IEEE 30th International Symposium on Computer-Based Medical Systems (CBMS).

[23]  Ting Chen,et al.  Deep Learning Based Automatic Immune Cell Detection for Immunohistochemistry Images , 2014, MLMI.

[24]  Jedd D. Wolchok,et al.  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy , 2016, Nature Reviews Clinical Oncology.

[25]  Ali Farhadi,et al.  YOLOv3: An Incremental Improvement , 2018, ArXiv.

[26]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[27]  Silun Xie,et al.  Allogenic natural killer cell immunotherapy of sizeable ovarian cancer: A case report , 2017, Molecular and clinical oncology.

[28]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[29]  T. Ivert,et al.  Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery , 2004, Cancer Immunology, Immunotherapy.

[30]  Ali Farhadi,et al.  YOLO9000: Better, Faster, Stronger , 2016, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[31]  Hai Su,et al.  Deep Voting: A Robust Approach Toward Nucleus Localization in Microscopy Images , 2015, MICCAI.

[32]  Chao Cheng,et al.  Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment. , 2017, Cancer research.

[33]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[34]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[35]  Guigang Zhang,et al.  Deep Learning , 2016, Int. J. Semantic Comput..

[36]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[37]  Ross A Soo,et al.  De-novo and acquired resistance to immune checkpoint targeting. , 2017, The Lancet. Oncology.